Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2013 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Topical Atropine for Childhood Myopia Control: The Atropine Treatment Long-Term Assessment Study.
JAMA Ophthalmol. 2024 Jan 1;142(1):15-23. doi: 10.1001/jamaophthalmol.2023.5467.
JAMA Ophthalmol. 2024.
PMID: 38019503
There was no difference in the 20-year incidence of cataract/lens opacities, myopic macular degeneration, or parapapillary atrophy (beta/gamma zone) comparing the 1% atropine-treated group vs the placebo group. ...
There was no difference in the 20-year incidence of cataract/lens opacities, myopic macular degeneration, or parapapillary …
Treatment of cystic macular lesions in hereditary retinal dystrophies.
Salvatore S, Fishman GA, Genead MA.
Salvatore S, et al.
Surv Ophthalmol. 2013 Nov-Dec;58(6):560-84. doi: 10.1016/j.survophthal.2012.11.006.
Surv Ophthalmol. 2013.
PMID: 24160730
Review.
Cystic macular lesions frequently contribute to impaired visual acuity in hereditary retinal dystrophies. ...We discuss the various factors and mechanisms implicated in the etiology of cystic macular lesions (anatomical abnormalities, impairment of the blood-retinal …
Cystic macular lesions frequently contribute to impaired visual acuity in hereditary retinal dystrophies. ...We discuss the various f …
Item in Clipboard
RPGR ORF15 genotype and clinical variability of retinal degeneration in an Australian population.
Ruddle JB, Ebenezer ND, Kearns LS, Mulhall LE, Mackey DA, Hardcastle AJ.
Ruddle JB, et al.
Br J Ophthalmol. 2009 Sep;93(9):1151-4. doi: 10.1136/bjo.2008.153908. Epub 2009 May 7.
Br J Ophthalmol. 2009.
PMID: 19429592
BACKGROUND: Mutations in the retinitis pigmentosa GTPase regulator gene (RPGR) are estimated to cause up to 20% of all Caucasian retinitis pigmentosa and up to 75% of cases of X-Linked RP (XLRP). Exon open reading frame 15 (ORF15) is a purine-rich mutation hotspot. …
BACKGROUND: Mutations in the retinitis pigmentosa GTPase regulator gene (RPGR) are estimated to cause up to 20% of all Caucasian retinitis p …
Item in Clipboard
Cite
Cite